What factors could drive LH's EPS growth in 2025?

Labcorp Holdings' (LH) EPS growth in 2025 is likely to be driven by a combination of factors, including:

1. **Strategic Acquisitions**: The acquisition of select assets from Invitae has enhanced Labcorp's offerings in genetic testing and contributed to revenue growth in oncology.
2. **New Product Launches**: The launch of innovative tests such as the HPV self-collection solution and STI testing options, which are FDA-approved, is expected to boost investor confidence and potentially increase revenue. These new products address unmet needs in the market and offer competitive advantages over traditional screening methods.
3. **Organic Revenue Growth**: The company's organic revenue growth, driven by factors such as new product introductions and an expanding customer base, is a key contributor to EPS growth.
4. **Cost Management**: Effective cost management, including the launch of the Labcorp® Plasma Complete™ liquid biopsy test, which reinforces its position in the genomics sector, and the spin-off of Fortrea Holdings, Inc., which potentially impacts focus on core operations, contributes to improved profitability.
5. **Shareholder Value**: Labcorp's commitment to shareholder value is evident through share repurchases and dividend payments, indicating solid cash flow management that supports EPS growth.
6. **Market Position**: Labcorp's strong market position in diagnostic testing and biopharma laboratory services, coupled with its ability to leverage partnerships and collaborations, such as with Xcell Biosciences, enhances its capabilities and positions it for growth.
7. **Industry Trends**: The overall growth in the medical diagnostics market, driven by factors such as an aging population, the rising burden of chronic diseases, and increasing healthcare expenditure, provides a favorable environment for LH's EPS growth.

In summary, LH's EPS growth in 2025 is expected to be driven by strategic acquisitions, new product launches, organic revenue growth, effective cost management, shareholder value, market position, and favorable industry trends.